Guests/Speakers
Lisa Goldman, Dr. Jonathan Goldman
What if you could take a pill to activate your own immune system to recognize and kill cancer cells? Learn the basics about immunotherapy for lung cancer in this discussion between patient advocate Lisa Goldman and Dr. Jonathan Goldman from the Ronald Reagan UCLA Medical Center.
Learn the answers to these questions:
What exactly is immunotherapy?
Is every lung cancer patient a candidate for immunotherapy?
Our immune systems work around the clock protecting our bodies from “foreign” substances such as bacteria and viruses. We know that this immune “surveillance” also protects us from cancer, by recognizing a cell that has become cancerous as something foreign. But cancers can evade our immune system.
Spontaneous mutations in the genes of a cancer cell cause the cells to be altered in such a way that they can no longer be recognized by our bodies as something foreign. They can also produce substances or proteins that can shield them from immune attack. #immunotherapy drugs can stop these shields and let the immune system attack the cancer or activate the body’s immune system to fight cancer. Often in pill form, immunotherapy for lung cancer is a major area of clinical research.
